130 related articles for article (PubMed ID: 3296302)
1. The single prostacyclin receptor of gel-filtered platelets provides a correlation with antiaggregatory potency of PGI2 mimics.
Eggerman TL; Hartzell CJ; Selfe S; Andersen NH
Thromb Res; 1987 Mar; 45(5):645-59. PubMed ID: 3296302
[TBL] [Abstract][Full Text] [Related]
2. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
Eggerman TL; Andersen NH; Robertson RP
J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
[TBL] [Abstract][Full Text] [Related]
3. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
4. Iloprost binding and inhibition of aggregation in platelet rich plasma. Differences between normal and type IIa hypercholesterolemic subjects.
Oliva DW; Maderna P; Accomazzo MR; Nicosia S; Tremoli E
Biochem Pharmacol; 1989 Jan; 38(1):39-45. PubMed ID: 2462881
[TBL] [Abstract][Full Text] [Related]
5. Heparin does not interfere with prostacyclin and prostaglandin D2 binding to platelets.
Fortini A; Modesti PA; Abbate R; Gensini GF; Neri Serneri GG
Thromb Res; 1985 Nov; 40(3):319-28. PubMed ID: 3001968
[TBL] [Abstract][Full Text] [Related]
6. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
[TBL] [Abstract][Full Text] [Related]
7. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury.
Kahn N; Sinha A; Bauman W
Clin Physiol; 2001 Jan; 21(1):60-6. PubMed ID: 11168298
[TBL] [Abstract][Full Text] [Related]
8. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
10. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
11. Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.
Kajikawa N; Nogimori K; Murata T; Nishio S; Uchiyama S
Arzneimittelforschung; 1989 Apr; 39(4):495-9. PubMed ID: 2665758
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of adenosine diphosphate-induced intravascular aggregation of rat platelets in vivo by 6-oxo-prostaglandin E1.
Oyekan AO; Botting JH
Prostaglandins; 1987 Sep; 34(3):359-66. PubMed ID: 3324168
[TBL] [Abstract][Full Text] [Related]
13. On the multiplicity of platelet prostaglandin receptors. I. Evaluation of competitive antagonism by aggregometry.
Andersen NH; Eggerman TL; Harker LA; Wilson CH; De B
Prostaglandins; 1980 May; 19(5):711-35. PubMed ID: 6252573
[TBL] [Abstract][Full Text] [Related]
14. Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet function.
Fisher CA; Kappa JR; Sinha AK; Cottrell ED; Reiser HJ; Addonizio VP
J Lab Clin Med; 1987 Feb; 109(2):184-90. PubMed ID: 2433373
[TBL] [Abstract][Full Text] [Related]
15. Platelet prostacyclin binding in smokers.
Jaschonek K; Weisenberger H; Tidow S; Daiss W; Renn W; Ostendorf P
J Lab Clin Med; 1986 Aug; 108(2):88-95. PubMed ID: 3016128
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of a novel circulating anti-prostacyclin receptor antibody.
Kahn NN; Bauman WA; Sinha AK
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8779-82. PubMed ID: 9238054
[TBL] [Abstract][Full Text] [Related]
17. On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs.
Tynan SS; Andersen NH; Wills MT; Harker LA; Hanson SR
Prostaglandins; 1984 May; 27(5):683-96. PubMed ID: 6087417
[TBL] [Abstract][Full Text] [Related]
18. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
Griffiths RJ; Moore PK
Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
[TBL] [Abstract][Full Text] [Related]
19. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury.
Kahn NN; Bauman WA; Sinha AK
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):245-9. PubMed ID: 8552614
[TBL] [Abstract][Full Text] [Related]
20. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
Miller OV; Gorman RR
J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]